Nicotinamide N-methyltransferase mediates lipofibroblast–myofibroblast transition and apoptosis resistance
Journal of Biological Chemistry · 2023-08 · 299 (8) · 105027
DOI: 10.1016/j.jbc.2023.105027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023-08. Verfasst von Mohammad Rehan und 9 weiteren Autor:innen. Beteiligte Einrichtung: John W. Deming Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA. Electronic address: mrehan@tulane.edu. Hauptthemen laut MEDLINE: Myofibroblasts, Nicotinamide N-Methyltransferase. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, BLRD VA, National Institutes of Health.
Abstract (Originalsprache)
Metabolism controls cellular phenotype and fate. In this report, we demonstrate that nicotinamide N-methyltransferase (NNMT), a metabolic enzyme that regulates developmental stem cell transitions and tumor progression, is highly expressed in human idiopathic pulmonary fibrosis (IPF) lungs, and is induced by the pro-fibrotic cytokine, transforming growth factor-β1 (TGF-β1) in lung fibroblasts. NNMT silencing reduces the expression of extracellular matrix proteins, both constitutively and in response to TGF-β1. Furthermore, NNMT controls the phenotypic transition from homeostatic, pro-regenerative lipofibroblasts to pro-fibrotic myofibroblasts. This effect of NNMT is mediated, in part, by the downregulation of lipogenic transcription factors, TCF21 and PPARγ, and the induction of a less proliferative but more differentiated myofibroblast phenotype. NNMT confers an apoptosis-resistant phenotype to myofibroblasts that is associated with the downregulation of pro-apoptotic members of the Bcl-2 family, including Bim and PUMA. Together, these studies indicate a critical role for NNMT in the metabolic reprogramming of fibroblasts to a pro-fibrotic and apoptosis-resistant phenotype and support the concept that targeting this enzyme may promote regenerative responses in chronic fibrotic disorders such as IPF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- John W. Deming Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA. Electronic address: mrehan@tulane.edu.
- John W. Deming Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA; Southeast Louisiana Veterans Health Care System, New Orleans, Louisiana, USA.
- Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
- John W. Deming Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA.
- John W. Deming Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA; Southeast Louisiana Veterans Health Care System, New Orleans, Louisiana, USA. Electronic address: vthannickal@tul…
Förderung
- NHLBI NIH HHS
- BLRD VA
- National Institutes of Health
- U.S. Department of Veterans Affairs
Zitieren
APA
Rehan, M., Deskin, B., Kurundkar, A. R., Yadav, S., Matsunaga, Y., Manges, J., Smith, N., Dsouza, K. G., Burow, M. E., & Thannickal, V. J. (2023). Nicotinamide N-methyltransferase mediates lipofibroblast–myofibroblast transition and apoptosis resistance. Journal of Biological Chemistry, 299(8), 105027. https://doi.org/10.1016/j.jbc.2023.105027
Vancouver
Rehan M, Deskin B, Kurundkar AR, Yadav S, Matsunaga Y, Manges J, et al. Nicotinamide N-methyltransferase mediates lipofibroblast–myofibroblast transition and apoptosis resistance. Journal of Biological Chemistry. 2023;299(8):105027. doi:10.1016/j.jbc.2023.105027
BibTeX
@article{Rehan2023,
author = {Rehan, Mohammad and Deskin, Brian and Kurundkar, Ashish R and Yadav, Santosh and Matsunaga, Yasuka and Manges, Justin and Smith, Nia and Dsouza, Kevin G and Burow, Matthew E and Thannickal, Victor J},
title = {Nicotinamide N-methyltransferase mediates lipofibroblast–myofibroblast transition and apoptosis resistance},
journal = {Journal of Biological Chemistry},
year = {2023},
volume = {299},
number = {8},
pages = {105027},
doi = {10.1016/j.jbc.2023.105027}
}
EUVIMED